Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: A retrospective study

Journal of Gastrointestinal Surgery

Volumn 12, Issue 2, 2008, Pages 327-337

  Wang, Zhi Li ^a   Liang, Ping ^a   Dong, Bao Wei ^a   Yu, Xiao Ling ^a   Yu, De Jiang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

C Met; Hepatic resection (HR); Metastasis and recurrence; Microwave ablation (MW); Small hepatocellular carcinoma (HCC); VEGF

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; SCATTER FACTOR RECEPTOR; VASCULOTROPIN A;

ADULT; ARTICLE; CATHETER ABLATION; CELL DIFFERENTIATION; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; TUMOR RECURRENCE;

ADULT; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CELL DIFFERENTIATION; DISEASE-FREE SURVIVAL; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-MET; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 47749103018     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-007-0310-0     Document Type: Review

References (35)

1. Nagashima I, Hamada C, Naruse K, Osada T, Nagao T, Muto T. Surgical resection for small hepatocellular carcinoma. Surgery 1996;119:40-45.
2. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, Kawasaki S. Surgery for small liver cancers. Semin Surg Oncol 1993;9:298-304.
3. Yamasaki S, Hasegawa H, Makuuchi M, Takayama T, Kosuge T, Shimada K. Choice of treatment for small hepatocellular carcinoma: hepatectomy, embolization or ethanol injection. J Gastro-enterol Hepatol 1991;6:408-413.
4. Dong BW, Liang P, Yu XL, Zeng XQ, Wang PJ, Su L, Wang XD, Xin H, Li S. Sonographically guided microwave coagulation treatment of liver cancer: an experimental and clinical study. AJR 1998;171:449-454.
5. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E, Nakamura T, Kojima T. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 1996;334:1561-1567.
6. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi Y, Kakizoe T. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomized trial. Lancet 2000;356:802-807.
7. Chen YJ, Ye SH, Chen JT, Wu CC, Hsu MT, Tsai SF, Chen PJ, Lin CH. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 2000;119:431-440.
8. Okada S, Shimada K, Yamamoto J, Takayama T, Kosuge T, Yamasaki S, Sakamoto M, Hirohashi S. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroen-terology 1994;106:1618-1624.
9. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-1440.
10. Mattern J, Koomagi R, Volm M. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res 1997;17:2249-2252.
11. Volm M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer 1997;74:64-68.
12. Compagni A, Wilgenbus P, Impagnatiello MA, Cotten M, Christofori G. Fibroblast growth factors are required for efficient tumor angiogenesis. Cancer Res 2000;60:7163-7169.
13. Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002;8:385-392.
14. Horiguchi N, Takayama H, Toyoda M, Otsuka T, Fukusato T, Merlino G, Takaqi H, Mori M. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncogene 2002;21:1791-1799.
15. Okada S. Local ablation therapy for hepatocellular carcinoma. Semin Liver Dis 1999;19:323-328.
16. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999;229:216-222.
17. Shimoyawa N, Hanayaki K. Long-term prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 2004;198:356-365.
18. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000;232:10-24.
19. Mise M, Arii S, Higashituji H, Furutani M, Niwano M, Harada T, Ishigami S, Toda Y, Nakayama H, Fukumoto M, Fujita J, Imamura M. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 1996;23:455-464.
20. Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT, Salgia R. Role of the hepatocyte growth factors receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev 2002;13:41-59.
21. Saftoiu A, Ciurea T, Banita M, Georgescu C, Comanescu V, Rogoveanu I, Gorunescu F, Georfescu I. Immunohistochemical assessment of angiogenesis in primary hepatocellular carcinoma. Rom J Gastroenterol 2004;13:3-8.
22. Chow NH, Cheng KS, Lin PW, Chan SH, Su WC, Sun YN, Lin XZ. Expression of fibroblast growth factor-1 and fibroblast growth factor-2 in normal liver and hepatocellular carcinoma. Dig Dis Sci 1998;43:2261-2266.
23. Okano J, Shiota G, Kawasaki H. Expression of hepatocyte growth factor (HGF) and HGF receptor (c-met) proteins in liver disease: and immunohistochemical study. Liver 1999;19:151-159.
24. Okada S. Local ablation therapy for hepatocellular carcinoma. Semin Liver Dis 1999;19:323-328.
25. Botha JF, Langnas AN. Liver transplantation for hepatocellular carcinoma: an update. J Natl Compr Canc Netw 2006;4:762-767.
26. Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, Xiao Q. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology 2005;235:299-307.
27. Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, Kunieda K, Sato M, Uchiyama S, Inoue K. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994;74:817-825.
28. Midorikawa T, Kumada K, Kikuchi H, Ishibashi K, Yagi H, Nagasaki H, Nemoto H, Saitoh M, Nakano H, Yamaguchi M, Koh Y, Sakai H, Yoshiyawa Y, Sanada Y, Yoshiba M. Microwave coagulation therapy for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2000;7:252-259.
29. Asahara T, Nakahara H, Fukuda T, Nakatani T, Yano M, Hino H, Okamoto Y, Katayama K, Itamoto T, Ono E, Dohi K, Kitamoto M, Nakanishi T. Percutaneous microwave coagulation therapy for hepatocellular carcinoma. Hiroshima J Med Sci 1998;47:151-155.
30. Shimada S, Hirota M, Beppu T, Matsuda T, Hayashi N, Tashima S, Takai E, Yamaguchi K, Inoue K, Ogawa M. Complications and management of microwave coagulation therapy for primary and metastatic liver tumors. Surg Today 1998;28:1130-1137.
31. Solbiati L, Tonolini M, Cova L. Monitoring RF ablation. Eur Radiol 2004;14(suppl 8):34-42.
32. Nakashima Y, Nakashima O, Tanaka M, Okuda K, Nakashima M, Kojiro M. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 2003;26:142-147.
33. Yoshiji H, Kuriyama S, Yoshii J, Yamazaki M, Kikukawa M, Tsujinoue H, Nakatani T, Fukui H. Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocel-lular carcinoma cells. Hepatology 1998;28:1489-1496.
34. Ueki T, Fujimoto J, Suzuki T, Yamamoto H, Okamoto E. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Hepatology 1997;25:862-866.
35. Poon RT, Ng IOL, Lau C, Yu WC, Fan ST, Wong J. Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma. Am Surg 2001;182:298-304.